2023 Fall Clinical Virtual Grand Rounds
2023 Virtual Grand Rounds Session 4: March 22, 2023 - SRT to Treat NMSC, Treating Filler Complications
About
Fall Clinical Virtual Grand Rounds consists of regularly scheduled CME sessions on a variety of dermatological diseases and tools, delivered by the top experts in dermatology.
Please join us for this week's session:
Wednesday, March 22, 2023
8 PM ET/ 5 PM PT
The Use of SRT to Treat NMSC
Identifying and Treating Filler Complications
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
March 22, 2023
March 22, 2024
Learning Objectives
At the completion of this activity, participants should be better able to:
Differentiate between different types of Radiation Therapy used to treat NMSC
Recognize the side effectives of different types or Radiation Therapy
Identify the types of complications that can occur with fillers for soft-tissue augmentation
Incorporate treatment regimens for dermal filler complications
Intended Audience
Faculty
Joel Cohen, MD
Medical Director
AboutSkin Dermatology and DermSurgery
Denver, CO
Gary Goldenberg, MD
Assistant Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Mark Nestor, MD, PhD
Director of Center for Clinical and Cosmetic Research
Voluntary Professor, Dermatology
University of Miami, Miller School of Medicine
Miami, FL
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
CONFLICTS OF INTEREST/DISCLOSURES
In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer.
Disclosures are as follows:
Grant/Research Support: Galderma, Allergan, Revance, Croma, Merz, BTL, Sciton, Brickell, Biofrontera, Revision, Sente, InMode
Consultant: Galderma, Allergan, Revance, Sciton, Revision, Sente, Biopelle, Biofrontera, Cutera
Speakers’ Bureau or Honoraria: Galderma, Sciton
Grant/Research Support: Biofrontera
Consultant: CoolHealth, Cutera, Galderma, Regeneron, Sanofi, Scibase
Speakers’ Bureau or Honoraria: Regeneron Sanofi
Ownership Interest: Verrica
Grant/Research Support: CROMA Pharma, Galderma, Merz
Consultant: CROMA Pharma, Revian, Sensus
Speakers’ Bureau or Honoraria: Allergan, AMP, Galderma, Hugel, Sensus
The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.